Suppr超能文献

肝素和其他多阴离子可使α1肾上腺素能受体与G蛋白解偶联。

Heparin and other polyanions uncouple alpha 1-adrenoceptors from G-proteins.

作者信息

Dasso L L, Taylor C W

机构信息

Department of Pharmacology, University of Cambridge, U.K.

出版信息

Biochem J. 1991 Dec 15;280 ( Pt 3)(Pt 3):791-5. doi: 10.1042/bj2800791.

Abstract

Several polyanionic compounds antagonize the interaction between receptors and the G-proteins that regulate adenylate cyclase or K+ channels, possibly by binding to a basic stretch of the receptor that is proposed to mediate its interaction with the G-proteins. We have studied the effects of polyanions on the interaction between the liver alpha 1-adrenoceptor and the G-protein through which it stimulates polyphosphoinositide turnover. Heparin [concn. causing 50% of maximal effect (EC50) = 0.5 microM], Trypan Blue (EC50 7.1 microM) or suramin (EC50 2.1 microM) prevented formation of the high-affinity adrenaline-receptor-G-protein complex without affecting antagonist binding. After alkaline treatment of the membranes, previously reported to cause G-protein removal, binding of agonists was insensitive to both guanine nucleotides and heparin. We conclude that these polyanions uncouple the alpha 1-adrenoceptor from its G-protein, suggesting that similar coupling mechanisms may underlie receptor activation of the G-proteins that activate polyphosphoinositide hydrolysis and those that regulate adenylate cyclase. This action of heparin severely limits its utility as a selective antagonist of the Ins(1,4,5)P3 receptor in intact cells.

摘要

几种聚阴离子化合物可拮抗受体与调节腺苷酸环化酶或钾通道的G蛋白之间的相互作用,可能是通过与受体的一段碱性区域结合来实现的,该区域被认为介导了受体与G蛋白的相互作用。我们研究了聚阴离子对肝脏α1-肾上腺素能受体与其刺激多磷酸肌醇代谢的G蛋白之间相互作用的影响。肝素[引起最大效应50%的浓度(EC50)=0.5微摩尔]、锥虫蓝(EC50 7.1微摩尔)或苏拉明(EC50 2.1微摩尔)可阻止高亲和力肾上腺素-受体-G蛋白复合物的形成,而不影响拮抗剂的结合。在对膜进行碱性处理后(先前报道这种处理可导致G蛋白去除),激动剂的结合对鸟嘌呤核苷酸和肝素均不敏感。我们得出结论,这些聚阴离子使α1-肾上腺素能受体与其G蛋白解偶联,这表明类似的偶联机制可能是激活多磷酸肌醇水解的G蛋白以及调节腺苷酸环化酶的G蛋白受体激活的基础。肝素的这种作用严重限制了其作为完整细胞中Ins(1,4,5)P3受体选择性拮抗剂的用途。

相似文献

引用本文的文献

2
The discovery and development of IP3 receptor modulators: an update.IP3 受体调节剂的发现和发展:最新进展。
Expert Opin Drug Discov. 2021 Jun;16(6):709-718. doi: 10.1080/17460441.2021.1858792. Epub 2021 Jan 6.
4
IP(3) receptors: toward understanding their activation.IP(3) 受体:探索其激活机制。
Cold Spring Harb Perspect Biol. 2010 Dec;2(12):a004010. doi: 10.1101/cshperspect.a004010. Epub 2010 Oct 27.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验